CEFTAZIDIME TAMRISA 2 g, powder for solution for injection (IV) 10 bottles
Active ingredients: Anhydrous ceftazidime, Ceftazidime pentahydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection10 bottlesintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFTAZIDIME TAMRISA 2 g, poudre pour solution injectable (IV)
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre
- Marketing authorisation holder
- TAMRISA ACCESS (FRANCE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Sept 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61432067CIP75704183CIP133400957041830Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CEFTAZIDIME PENTAHYDRATÉEpoudre | — | SA |
| CEFTAZIDIME ANHYDREpoudre | 2 g · un flacon de poudre | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: CEFTAZIDIME 2 g - FORTUM 2 g, poudre pour solution injectable (IV) ou pour perfusion.
